Info@ThinkPinkRocks.com

FDA authorizes marketing of new Aera system to treat patients with chronic ETD symptoms

The U.S. Food and Drug Administration today permitted marketing of a device that uses a small balloon to treat persistent Eustachian tube dysfunction (ETD), a condition in which pressure, pain or clogged or muffled sensations occur in the ear.

See more here:
FDA authorizes marketing of new Aera system to treat patients with chronic ETD symptoms

Share

Leave a Reply